Merck makes a big move into new cancer treatments with a $6.7 billion
buyout deal
-
Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is
developing an oral treatment for leukemia.
30 minutes ago





... the rising cost of living in the country and the growing social divide it is creating. This social movement of people demanding their share
ReplyDelete